⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL491681 | 0.59 | — | — | |
| SCHEMBL13006360 | 0.59 | — | — | |
| SCHEMBL491682 | 0.59 | — | — | |
| SCHEMBL25922 | 0.59 | — | — | |
| Hydrochloric Acid SCHEMBL11441384 | 0.56 | — | — | |
| SCHEMBL463141 | 0.56 | — | — | |
| SCHEMBL14838222 | 0.56 | — | — | |
| Hydrochloric Acid SCHEMBL11441382 | 0.56 | — | — | |
| SCHEMBL1289422 | 0.56 | — | — | |
| Lithium SCHEMBL31512253 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1991013623-A1 | C-5 MONO-SUBSTITUTED BARBITURATES IN COMBINATION WITH THERAPEUTIC AGENTS AND USES THEREOF | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1991-09-19 | — | — | WO | claimed |
| EP-0321556-A4 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | — | 1991-06-12 | — | — | EP | claimed |
| US-4880811-A | SIDE EFFECT REDUCTION; NONSEDATING; GOUT; ANTIARTHRITIC AGENTS; METABOLIC, BLOOD AND GENETIC DISORDERS | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1989-11-14 | — | — | US | claimed |
| EP-0321556-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | Memorial Hospital for Cancer and Allied Diseases (US) | 1989-06-28 | — | — | EP | claimed |
| WO-1988010114-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1988-12-29 | — | — | WO | claimed |
| WO-1991013623-A1 | C-5 MONO-SUBSTITUTED BARBITURATES IN COMBINATION WITH THERAPEUTIC AGENTS AND USES THEREOF | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1991-09-19 | — | — | WO | disclosed |
| EP-0321556-A4 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | — | 1991-06-12 | — | — | EP | disclosed |
| US-4880811-A | SIDE EFFECT REDUCTION; NONSEDATING; GOUT; ANTIARTHRITIC AGENTS; METABOLIC, BLOOD AND GENETIC DISORDERS | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1989-11-14 | — | — | US | disclosed |
| EP-0321556-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | Memorial Hospital for Cancer and Allied Diseases (US) | 1989-06-28 | — | — | EP | disclosed |
| WO-1988010114-A1 | USE OF C-5 MONO-SUBSTITUTED BARBITURATES TO TREAT DISORDERS OF URIC ACID METABOLISM | MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (US) | 1988-12-29 | — | — | WO | disclosed |